Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of medicament and weight ratio, applied in the field of medicine, can solve the problems of adverse reactions, many interference factors, and unsatisfactory curative effect, etc., and achieve the effect of clear curative effect and good safety.
Inactive Publication Date: 2013-06-19
张丽
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Modern medicine usually uses common sedative drugs in the treatment of insomnia, but for some intractable insomnia, because there are many interference factors, the curative effect of using common sedative drugs is often not ideal, and most of these sedative drugs are likely to cause many complications. Adverse reactions, long-term use will lead to dependence, drug resistance, and side effects such as damage to liver and kidney functions. Therefore, ordinary sedative drugs should not be taken for a long time
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0009] Embodiment Decoction of the present invention
[0010] Weigh 7 grams of Scrophulariae, 13 grams of dried ginger, 22 grams of dogwood, 15 grams of platycodon, 21 grams of coptis, 13 grams of chrysanthemum, 28 grams of goldenrod, 11 grams of Tianxianzi, 17 grams of ephedra, 24 grams of Shiwei, and 27 grams of hawthorn , 18 grams of Morinda officinalis, 17 grams of celandine, 23 grams of cocklebur root, 21 grams of cocklebur, 16 grams of emblica, 16 grams of Jiulixiang, 17 grams of morning glory, 19 grams of golden boiling grass, and 15 grams of sarcophagus , Polygala 14g, Senna 21g, Blue Buzheng 11g, Leulu 13g, Manshanhong 23g, White Grass 24g, Black Plum 14g, Artemisia argyi 25g, Yemachai 26g, Horsetail 16g gram and 24 grams of ramie, add 2000 milliliters of water, heat at 80° C. for 4 hours in a flask equipped with a condenser tube, and filter. Concentrate the filtrate to 600 milliliters to obtain the decoction of the present invention.
experiment example
[0012] Diagnostic criteria:
[0013] Refer to "Chinese Mental Disease Classification Scheme and Diagnostic Criteria CCMD-2" (Chinese Neuropsychiatric Society. Chinese Mental Disease Classification Scheme and Diagnostic Criteria ((CCMD-2) [J] Chinese Journal of Neuropsychiatry, 1986, 19(5): 318-320) to make a diagnosis of insomnia. At the same time, all patients should be ruled out whether the insomnia is caused by factors such as brain, nervous system, physical disease or taking drugs; the patients should be given routine physical examination, including liver, Kidney function tests, blood, urine, and stool routine tests, and electrocardiograms, etc.
[0014] Selected 80 cases that met the diagnostic criteria, including 40 males with an average age of 45 years and 40 females with an average age of 51 years.
[0015] treatment plan
[0016] Use the decoction prepared in the embodiment for treatment, 2 times a day, each oral administration of 50 milliliters. Continuous treatme...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a drug for treating insomnia. The drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of coptis chinensis, 5-15 parts of chrysanthemum, 10-30 parts of woundwort, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of hawthorn, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of polygala tenuifolia, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of smoked plum, 15-25 parts of folium artemisiae argyi, 20-30 parts of lindley eupatorium, 1-20 parts of horsetail and 10-25 parts of chinese azalea flower. All the components of the drug for treating insomnia in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating insomnia. Background technique [0002] Insomnia is a common and frequently-occurring disease in clinical practice. Once it occurs, it will have a great negative impact on the daily work and life of the patient. Modern medicine usually uses common sedative drugs in the treatment of insomnia, but for some intractable insomnia, because there are many interference factors, the curative effect of using common sedative drugs is often not ideal, and most of these sedative drugs are likely to cause many complications. Adverse reactions, long-term use will lead to dependence, drug resistance, and side effects such as damage to liver and kidney functions. Therefore, ordinary sedative drugs should not be taken for a long time. Currently, there is an increasing demand for drugs for the treatment of insomnia. Contents of the invention [0003] The object of the present i...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more